UiPath price target raised to $16 from $14 at Canaccord

Canaccord analyst Kingsley Crane raised the firm’s price target on UiPath (PATH) to $16 from $14 and keeps a Buy rating on the shares. The firm said the company started off FY26 with a cleaner-than-expected beat and raise helped by a favorable deal mix that benefited license revenue performance via 606 recognition. Canaccord thinks there is a path for the firm to work NRR toward the mid- teens over the next few years with gradual margin leverage to achieve a more balanced Rule of 40.